top of page

Treatment
TREATMENT FOR OVARIAN CANCER
One of the most exciting things emerging in the biomedical fields currently is the idea of personalized medicine. Given a patient’s genetic makeup and risk factors, can we optimize treatment regimens to maximize impact on a patient’s prognosis and survival? Some key questions in this area include:
-
What is the biological basis for treatment resistance?
-
What combinations of mutations are more/less likely to respond to treatment?
-
How do various cell models respond to common chemotherapies?
-
Does genetic predisposition (e.g. BRCA mutations) play a role in treatment outcomes?
PUBLICATIONS
bottom of page